drugset / Trial / NCT06558071

Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating Mothers

NCT06558071 ↗

Phase 3 Completed 160 enrolled Dexa Medica Group
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, double-blind, and placebo-controlled study involving mothers as the participant and participant's babies evaluating the effect of a 15-day-supplementation with a product containing extracts derived from a combination of herbal plants (katuk \& torbangun leaves) and snakehead fish in stimulating breast milk production.

Timeline

Start
2024-10-21
Primary completion
2025-05-20
Completion
2025-05-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Galatonol Unknown 300 mg —
Subject Striatin Unknown 30 mg —

Indications